🔎 Trials Near Me

Beranda › Kanker Kandung Kemih › Pennsylvania › Philadelphia

Uji klinis Kanker Kandung Kemih di Philadelphia, PA

21 studi untuk Kanker Kandung Kemih mencari peserta di lokasi sekitar Philadelphia (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Menerima pesertaFase 2
  • Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06770582

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Menerima peserta
  • Abramson Cancer Center, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07048496

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Menerima pesertaFase 3
  • Fox Chase Cancer Center, Philadelphia
  • Fox Chase Cancer Center-Rockledge, Rockledge · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07000084

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi jauhnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Menerima pesertaFase 2
  • MidLantic Urology ( Site 0102), Bala-Cynwyd · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06833073

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Menerima pesertaFase 2
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
  • Asplundh Cancer Pavilion, Willow Grove · 13 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07061964

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Menerima pesertaFase 1
  • Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07277413

DESTINY-PANTUMOUR04

Menerima pesertaStudi observasional
  • Research Site, Philadelphia
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000

Prehabilitation in High-risk Oncologic Surgery

Menerima peserta
  • Fox Chase Cancer Center - Philadelphia, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07638410

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Menerima pesertaFase 1
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07217171

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Menerima pesertaStudi observasional
  • University of Pennsylvania, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05059444

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Menerima pesertaFase 2
  • University of Pennsylvania, Philadelphia
  • Midlantic Urology (Solaris), Bala-Cynwyd · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06567743

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Menerima pesertaFase 1
  • University of Pennsylvania, Philadelphia
  • Thomas Jefferson University, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT05614739

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Menerima pesertaFase 3
  • Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi jauhnya
  • Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07097142

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Menerima pesertaFase 1/2
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT04752722

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Menerima pesertaFase 2
  • Thomas Jefferson University, Philadelphia
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

Menerima pesertaFase 1
  • University of Pennsylvania, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT06586255

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • University of Pennsylvania, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Feb 2026 · NCT07030257

Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

Menerima peserta
  • Thomas Jefferson University Hospital, Philadelphia
  • Jefferson Einstein Philadelphia Hospital, Philadelphia
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT07234968

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Menerima pesertaFase 1
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT06778863

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Philadelphia
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Uji klinis Kanker Kandung Kemih di kota lain

Studi lain di Philadelphia

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.